Skip to main content
Premium Trial:

Request an Annual Quote

Jane Dancer, Chris Kendrick-Parker, Peter White; Moharem El Gihani

Premium
Cellzome this week announced the appointment of Jane Dancer as vice president of business development. Until recently, she had been director of business development at MedImmune. Prior to that, she was global project manager at Aventis Crop Science.
 

 
Gentel Biosciences this week appointed Chris Kendrick-Parker to its board of directors. Kendrick-Parker has held various positions at Affymetrix and Amersham Pharmacia
 

 
Cambridge Research Biochemicals this week said Peter White has joined the firm as consultant technical director. Moharem El Gihani also joined the company as business development director. Cambridge is a supplier of custom peptides and antibodies to pharmaceutical companies.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.